AIM ImmunoTech Inc. Gains 61.26%

AIM ImmunoTech Inc. (AIM:NYSEMKT) soared at $0.41, representing a gain of 61.3%. On Mon, May 18, 2026, AIM:NYSEMKT hit a New 2-Week Intraday High of $0.69. The stock got featured on our News Catalysts scanner on Thu, May 14, 2026 at 11:27 AM in the 'BIOTECH' category. From Mon, May 04, 2026, the stock recorded 20.00% Up Days and 27.27% Green Days

The stock spiked on Mon, May 18, 2026 at $0.69 with a volume of 465M+.

About AIM ImmunoTech Inc. (AIM:NYSEMKT)

AIM ImmunoTech Inc is a US-based specialty pharmaceutical company. It is engaged in the clinical development of drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune-based disorders. The products of the firm are Alferon N Injection and the experimental therapeutic Ampligen. Alferon N Injection is approved for a category of STD infection, and Ampligen represents a RNA being developed for viral diseases and disorders of the immune system. The sales revenue of the company is derived from the United States.